Occam's Strategic Partnership with Geron Continues with the Placement of Head of R&D
In November 2024, Joseph Eid, MD, was placed by Occam Global as Executive Vice President, Research and Development of Geron Corporation (Nasdaq: GERN), a commercial-stage oncology biopharma.
In this role, Dr. Eid will lead the Research and Development department for the organization, including medical, clinical, and safety/pharmacovigilance teams. He will drive innovative strategies to support the commercial success of RYTELO™ and ensure ongoing research opportunities.
Dr. Eid has over twenty years of experience in medical affairs and clinical development in the biopharmaceutical industry. Recently, he led medical affairs and research at Dragonfly Therapeutics as President of Research and Development. Previously, he served as Executive Vice President and Chief Medical Officer at Luzsana Bio, a subsidiary of Hengrui Pharmaceuticals. Dr. Eid began his career in oncology drug development at Roche in 2004 before joining Merck in 2009.
Dr. Eid’s appointment marks Occam’s eighth high-profile executive placements, including the Chief Commercial Officer, Chief Financial Officer, Chief Legal Officer, Chief Business Officer, and three Board members. Geron exemplifies Occam Global as a long-term strategic partner for a public biotech company rebuilding for the commercial stage.
Occam Global is an international life science executive search and leadership advisory firm dedicated to building management teams for innovative companies in the biotech, techbio, life sciences, and venture capital sectors. Our firm’s unique strength lies in our seamless access to elite talent, proven expertise in aligning exceptional business and scientific leaders with optimal opportunities, and a steadfast dedication to creating meaningful industry impact, guided by elevated ethics and enlightened aggression. Trusted by entrepreneurs, investors, and corporations worldwide, Occam Global is recognized as the premier partner for executive search and recruitment in the life sciences. Our success is rooted in establishing trust, cultivating and valuing relationships, and committing to serve as forthright and good-humored partners in realizing extraordinary ambitions.